Effects of poststroke losartan versus captopril treatment on myogenic and endothelial function in the cerebrovasculature of SHRsp

Stroke

Volumn 38, Issue 5, 2007, Pages 1590-1596

  Smeda, John S ^a,b   McGuire, John J ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Captopril; Endothelium; Intracerebral hemorrhage; Myogenic response; SHRsp

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; BRADYKININ; CALCIMYCIN; CAPTOPRIL; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTERY CONSTRICTION; ARTICLE; AUTOREGULATION; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME INHIBITION; HYPERTENSION; MALE; MIDDLE CEREBRAL ARTERY; MUSCLE DEVELOPMENT; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RECEPTOR BLOCKING; STROKE; TREATMENT RESPONSE; VASODILATATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CAPTOPRIL; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; LOSARTAN; MALE; RATS; RATS, INBRED STRAINS; RECEPTOR, ANGIOTENSIN, TYPE 1; VASCULAR DISEASES; VASODILATION;

EID: 34247582830     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.106.475087     Document Type: Article

References (12)

1. Smeda JS, Vasdev S, King SR. Effect of poststroke captopril treatment on mortality associated with hemorrhagic stroke in stroke-prone rats. J Pharmacol Exp Ther. 1999;291:569-575.
2. Smeda JS. Hemorrhagic stroke development in spontaneously hypertensive rats fed a North American Japanese-style diet. Stroke. 1989;20:1212-1218.
3. Smeda JS, King S. Electromechanical alterations in the cerebrovasculature of stroke-prone rats. Stroke. 2000;31:751-758.
4. Smeda JS, Van Vliet BN, King S. Stroke-prone spontaneously hypertensive rats lose their ability to auto-regulate cerebral blood flow. J Hypertens. 1999;17:1697-1705.
5. Ukaka K, Takeuchi Y, Movat HZ. Simple method for quantitation of enhanced vascular permeability. Proc Soc Exp Biol Med. 1970;133:1384-1387.
6. Camargo MJF, von Lutterotti N, Pecker MS, James GD, Timmermans PB, Laragh JH. DuP 753 increases survival in spontaneously hypertensive stroke-prone rats fed a high sodium diet. Am J Hypertens. 1991;4(suppl):3441S-3345S.
7. Bolterman RJ, Manriquez MC, Ortiz Ruiz MC, Juncos LA, Romero JC. Effects of captopril on the rennin-angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension. 2005;46:943-947.
8. Carey RM. Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age. Hypertension. 2005;45:840-844.
9. Carey RM. Update on the role of the AT-2 receptor. Curr Opin Nephrol Hypertens. 2005;14:67-71.
10. Thone-Reineke C, Zimmermann M, Neumann C, Krikov M, Li J, Gerova N, Unger T. Are angiotensin receptor blockers neuroprotective? Curr Hypertens Rep. 2004;6:257-266.
11. Siragy HM, Carey RM. Protective role of the angiotensin AT2 receptor in a renal-wrap hypertension model. Hypertension. 1999;33:1237-1242.
12. Hashimoto N, Maeshima Y, Satoh M, Odawara M, Sugiyama H, Kashihara N, Matsubara H, Yamasaki Y, Makino H. Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model. Am J Physiol. 2004;286:F516-F525.